ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,235.55
      0.36%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV
      6. Regeneron Pharmaceuticals Inc (REGN34)

      7. Regeneron Pharmaceuticals Inc (REGN34) Financials

      REGN34 Regeneron Pharmaceuticals Inc

      93.15
      1.60 (1.75%)
      Jun 14 2024 - Closed
      Delayed by 15 minutes

      Regeneron Pharmaceuticals Financial Summary

      The current REGN34 market cap is 9.98B. The company's latest EPS is USD 36.9050 and P/E is 28.09.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 3.16B3.16B3.36B3.43B3.15B
      Operating Income 946.7M1.02B1.11B972.9M751.4M
      Net Income 817.8M968.4M1.01B1.16B722M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 7.86B8.78B16.12B12.26B13.12B
      Operating Income 2.21B3.58B8.95B4.74B4.05B
      Net Income 2.12B3.51B8.08B4.34B3.95B

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 30.06B30.66B32.16B33.08B34.37B
      Total Liabilities 6.56B6.64B7.26B7.11B7.38B
      Total Equity 23.5B24.02B24.9B25.97B26.99B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 14.81B17.16B25.43B29.21B33.08B
      Total Liabilities 3.72B6.14B6.67B6.55B7.11B
      Total Equity 11.09B11.03B18.77B22.66B25.97B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 1.37B2.39B3.5B4.59B1.51B
      Investing -235.7M-2.62B-3.12B-3.19B-1.69B
      Financing -322.5M-936.7M-1.34B-1.79B47.1M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 2.43B2.62B7.08B5.01B4.59B
      Investing -2.03B-70.6M-5.38B-3.78B-3.19B
      Financing -252.1M-1.97B-1.01B-1.01B-1.79B

      Stats and Ratios

      Market Cap 9.98B
      Price to Earnings Ratio 28.09
      Price to Sales Ratio 8.46
      Price to Cash Ratio 40.67
      Price to Book Ratio 4.28
      Dividend Yield -

      Share Statistics

      Shares Outstanding 107.13M
      Average Volume (1 week) 1.51k
      Average Volume (1 Month) 921
      52 Week Change 50.44%
      52 Week High 93.17
      52 Week Low 55.99
      Spread (Intraday) 29.17 (31.31%)

      Company Info

      Company Name Regeneron Pharmaceuticals Inc
      Address 28 liberty street
      new york, new york 10005
      Website https://www.regeneron.com
      Industry health care diversified (H)